Including Advances in Hematologic Malignancies and a Special Focus on Myelodysplastic Syndromes
Take a first look at what's new in clinical hematology and hematology-oncology.
September 27-28, 2013
October 11-12, 2013
Los Angeles, CA
Both SAS meetings will feature leading hematology experts who will discuss recent advances in hematologic malignancies, with a special focus on myelodysplastic syndromes.
- Case-based presentations by renowned speakers
- Interactive discussions with speakers and colleagues
- Opportunity to earn AMA PRA Category 1 Credits™
- Special trainee activities
- Networking "Lunch with the Experts"
About the Meeting
The 2013 State-of-the-Art Symposium provides up-to-date, evidence-based continuing medical education that spans the medical field and practice of hematology. The smaller, clinically focused program format provides attendees with ample opportunities to discuss their actual patient cases and practice challenges with experts in the field. Additionally, in order to enhance the exchange of information, panel discussions and "Lunch with the Experts" are offered in the meeting content.
ASH strongly encourages attendees who are currently enrolled in training programs at their institutions to attend SAS. There will be dedicated time for trainees to network with speakers and a forum to discuss specific cases and questions.
Checking this page for new information?Join a mailing list to receive email about important news and updates on the upcoming SAS meetings.
Roy L. Silverstein, MD
Medical College of Wisconsin
Blood Center of Wisconsin
David P. Steensma, MD
Harvard Medical School
Dana-Farber Cancer Institute
2013 SAS State Society Partners
- Illinois Medical Oncology Society (IMOS)
- Indiana Oncology Society (IOS)
- Iowa Oncology Society (IOS)
- Michigan Society of Hematology and Oncology (MSHO)
- Missouri Oncology Society (MOS)
- Medical Oncology Association of Southern California (MOASC)
- The Arizona Clinical Oncology Society (TACOS)
This year's corporate supporters are as follows:
Lead Commercial Supporter
- Amgen, Inc
- Incyte Corporation
- Millennium: The Takeda Oncology Company
- Seattle Genetics
General Meeting Supporter
- Gilead Sciences, Inc.
- Novartis Pharmaceuticals, Inc.
Visit ASH's Acknowledgement of Commercial Support page for more support information.
Purchase Past SAS Meeting Products
In case you missed the 2012 State-of-the-Art Symposium, you can purchase the DVD of the meeting through the ASH Store. The DVD features audio synchronized to the slides of each of the presentations from this event.
Visit the past meetings page to learn more about what you can expect from the SAS meetings.
ASH will have a professional photographer and/or videographer present at the meeting; therefore, please note that any photographs or videos taken at the meeting may be used in future ASH publications, on the ASH website, or in other Society materials. Attendance or participation in the meeting constitutes an agreement with ASH by the registrant for the Society to use and distribute the registrant's image or voice in photographs, videotapes, audiotapes, or other electronic media pertaining to the meeting events and activities.
The American Society of Hematology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Hematology designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians not licensed in the United States who participate in this CME activity are also eligible for AMA PRA Category 1 Credits™.
CME Certificate Eligibility
ASH is accredited to provide AMA PRA Category 1 Credits™ to physicians only. The AMA defines physicians as those individuals who have obtained an MD, DO or equivalent medical degree from another country.
Non-physicians and other health-care professionals attending the meeting can receive a Certificate of Attendance.
back to top